These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11116050)
1. In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension. Kim S; Zhan Y; Izumi Y; Yasumoto H; Yano M; Iwao H Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2539-45. PubMed ID: 11116050 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats. Kim S; Zhan Y; Izumi Y; Iwao H Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593 [TBL] [Abstract][Full Text] [Related]
3. Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening. Abe J; Deguchi J; Matsumoto T; Takuwa N; Noda M; Ohno M; Makuuchi M; Kurokawa K; Takuwa Y Circulation; 1997 Sep; 96(6):1906-13. PubMed ID: 9323080 [TBL] [Abstract][Full Text] [Related]
4. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats. Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951 [TBL] [Abstract][Full Text] [Related]
5. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats. Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594 [TBL] [Abstract][Full Text] [Related]
6. The angiotensin I-converting enzyme inhibitor, cilazapril inhibits the platelet-derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats. Yamauchi T; Ogura T; Oishi T; Omiya T; Ota Z Ren Physiol Biochem; 1995; 18(5):237-45. PubMed ID: 8869081 [TBL] [Abstract][Full Text] [Related]
7. Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats. Izumi Y; Kim S; Zhan Y; Namba M; Yasumoto H; Iwao H Hypertension; 2000 Oct; 36(4):511-6. PubMed ID: 11040228 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation. Clark MA; Gonzalez N Regul Pept; 2007 Dec; 144(1-3):115-22. PubMed ID: 17688958 [TBL] [Abstract][Full Text] [Related]
9. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction. Watts SW; Florian JA; Monroe KM J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408 [TBL] [Abstract][Full Text] [Related]
10. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition augments the expression of rat elastase-2, an angiotensin II-forming enzyme. Becari C; Teixeira FR; Oliveira EB; Salgado MC Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H565-70. PubMed ID: 21602471 [TBL] [Abstract][Full Text] [Related]
13. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290 [TBL] [Abstract][Full Text] [Related]
14. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. Paull JR; Widdop RE J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II maintains cerebral vascular relaxation via EGF receptor transactivation and ERK1/2. McEwen ST; Balus SF; Durand MJ; Lombard JH Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1296-303. PubMed ID: 19684181 [TBL] [Abstract][Full Text] [Related]
16. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of AT1 receptor internalization by concanavalin A blocks angiotensin II-induced ERK activation in vascular smooth muscle cells. Involvement of epidermal growth factor receptor proteolysis but not AT1 receptor internalization. Tang H; Nishishita T; Fitzgerald T; Landon EJ; Inagami T J Biol Chem; 2000 May; 275(18):13420-6. PubMed ID: 10788453 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Kagiyama S; Eguchi S; Frank GD; Inagami T; Zhang YC; Phillips MI Circulation; 2002 Aug; 106(8):909-12. PubMed ID: 12186792 [TBL] [Abstract][Full Text] [Related]
19. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Rentzsch B; Todiras M; Iliescu R; Popova E; Campos LA; Oliveira ML; Baltatu OC; Santos RA; Bader M Hypertension; 2008 Nov; 52(5):967-73. PubMed ID: 18809792 [TBL] [Abstract][Full Text] [Related]
20. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme. Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]